Evolving views in prion glycosylation: functional and pathological implications

Myriam Ermonval (1, 2) , Sophie Mouillet-Richard (1, 2) , Patrice Codogno (3) , Odile Kellermann (1, 2) , Joëlle Botti (3)

1 IP - Institut Pasteur [Paris]
2 CNRS - Centre National de la Recherche Scientifique
3 Glycobiologie et signalisation cellulaire

Prion diseases form a group of neurodegenerative disorders with the unique feature of being transmissible. These diseases involve a pathogenic protein, called PrP(Sc) for the scrapie isoform of the cellular prion protein (PrP(C)) which is an abnormally-folded counterpart of PrP(C). Many questions remain unresolved concerning the function of PrP(C) and the mechanisms underlying prion replication, transmission and neurodegeneration. PrP(C) is a glycosyl-phosphatidylinositol-anchored glycoprotein expressed at the cell surface of neurons and other cell types. PrP(C) may be present as distinct isoforms depending on proteolytic processing (full length and truncated), topology(GPI-anchored, transmembrane or soluble) and glycosylation (non- mono- and di-glycosylated). The present review focuses on the implications of PrP(C) glycosylation as to the function of the normal protein, the cellular pathways of conversion into PrP(Sc), the diversity of prion strains and the related selective neuronal targeting.

Keywords: Prion; Glycosylation; Neurodegenerative diseases

Domains: Life Sciences [q-bio]

Myriam Ermonval, Sophie Mouillet-Richard, Patrice Codogno, Odile Kellermann, Joëlle Botti. Evolving views in prion glycosylation: functional and pathological implications. Biochimie, 2003, 85 (1-2), pp.33-45. ⟨10.1016/s0300-9084(03)00040-3⟩. ⟨pasteur-03204688⟩